A review of the safety and efficacy of benzoyl peroxide (5.3%) emollient foam in the management of truncal acne vulgaris

Journal of Clinical and Aesthetic Dermatology

Volumn 3, Issue 11, 2010, Pages

  Bikowski, Joseph ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b Bikowski Skin Care Center at Sewickley Station   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE WASH; BENZEFOAM; BENZOYL PEROXIDE; EMOLLIENT AGENT; UNCLASSIFIED DRUG;

ACNE VULGARIS; ANTIBACTERIAL ACTIVITY; BACTERIAL COUNT; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRY SKIN; ERYTHEMA; FOAM; HUMAN; MOISTURE; MONOTHERAPY; NONHUMAN; PROPIONIBACTERIUM ACNES; PRURITUS; REVIEW; SHORT COURSE THERAPY; SKIN BURNING SENSATION; SKIN MANIFESTATION; SKIN PENETRATION; SKIN SCALING;

EID: 78649232301     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Del Rosso JQ. Management of truncal acne vulgaris: current perspectives on treatment. Cutis. 2006;77(5):285-289.
2. Tan JK, Tang J, Fung K, et al. Prevalence and severity of facial and truncal acne in a referral cohort. J Drugs Dermatol. 2008;7(6):551-556.
3. Del Rosso JQ, Bikowski J, Baum E. Prevalence of truncal acne vulgaris: a population study based on private practice experience. Poster presented at: 65th Annual Meeting of the American Academy of Dermatology; February 2-6, 2007; Washington, DC.
4. Del Rosso JQ. Therapeutic cleansers: keeping it clean. Skin & Aging. 2003:11:83-88.
5. Del Rosso JQ. Pharmacotherapy update: managing truncal acne vulgaris. Skin & Aging. 2005;13(8):66-71.
6. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-S37.
7. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1-S50.
8. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007;79(6 Suppl):9-25.
9. Kligman AM. Acne vulgaris: tricks and treatments. Part II. The benzoyl peroxide saga. Cutis. 1995; 56(5):260-261.
10. Tanghetti E, Popp K. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin. 2009;27(1):17-24.
11. Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis. 2008; 82(6):417-421.
12. Leyden JJ. Efficacy of benzoyl peroxide (5.3%) emollient foam and benzoyl peroxide (8%) wash in reducing Propionibacterium acnes on the back. J Drugs Dermatol. 2010;9(6):622-625.
13. Data on File. Cumberland, RI: Onset Therapeutics; 2010.